NEWS

EMA establishes task force to take quick and coordinated regulatory action related to COVID-19 medicines

As part of its health threat plan activated to fight COVID-19, the Agency has finalised and published the composition and objectives of its COVID-19 EMA pandemic Task Force (COVID-ETF), which assists Member States and the European Commission in dealing with development, authorisation and safety monitoring of therapeutics and vaccines intended for treatment or prevention of COVID-19. The main Read more about EMA establishes task force to take quick and coordinated regulatory action related to COVID-19 medicines[…]

Science & SciLifeLab Prize for Young Scientists – Open for Applications

The young scientists’ prize award by SciLifeLab together with Science/AAAS – the Science & SciLifeLab Prize for Young Scientists is now open for applications! Four recent PhDs are selected as winners and will be published by Science, receive up to 30,000 USD and be invited to Sweden to receive their awards, present their research, and Read more about Science & SciLifeLab Prize for Young Scientists – Open for Applications[…]

H2020: IF & COFUND calls

The EU has opened yesterday #2 important calls. Info and details are listed here. Individual Fellowships: MSCA-H2020-IF-2020 Objective. The goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced training, international and intersectoral mobility. Individual Fellowships Read more about H2020: IF & COFUND calls[…]

BBMRI-ERIC has released COVID-19 specific support

What can biobanks do against COVID-19? Taking care of today’s COVID-19 patients is priority number 1. Researchers will need high quality samples from patients and healthy controls, collected in clinical settings and in an ethical way. BBMRI-ERIC can all help with that. In the past weeks, BBRMI collected information on the resources national nodes and Read more about BBMRI-ERIC has released COVID-19 specific support[…]

GA4GH Virtual Connect 2020 Meeting Report and Resources Now Available

The GA4GH meeting was online due to the Covid-19 outbreak. The level of participation and engagement of participants coming from different geographical locations have motivated the organizers to develop resources and materials collected during the virtual meeting and make them available to everyone. Here are the links to view the Meeting Reports on the website Read more about GA4GH Virtual Connect 2020 Meeting Report and Resources Now Available[…]

Anti-Covid-19 drugs

There is no anti-Covid-19 drug globally accepted for treatment, but many drugs are under investigations. About 16 trials of antivirals are under development (6 march 2020). Antiviral drugs are difficult to find, because of the cell-parasitic nature of viruses. It has been long to get efficient drugs against HIV or Hepatitis C. COVID-19 vaccine may Read more about Anti-Covid-19 drugs[…]

Building a data strategy for the European Reference Networks – A EURORDIS contribution

EURORDIS has launched a new contribution on ERNs and health data to trigger a strategic discussion on health data and ERNs that will allow the Networks to have a long-term strategy that is aligned with their needs and ambition. The proposal aims to progress towards developing a comprehensive ERN data strategy that is structured around Read more about Building a data strategy for the European Reference Networks – A EURORDIS contribution[…]

COVID-19 Public Health Emergency of International Concern (PHEIC)

Global research and innovation forum: towards a research roadmap The World Health Organization (WHO) has recently developed and launched this official document to Powering research to control the epidemic. Broad consensus on the need for research to focus on actions that can save lives now. To ensure that those affected are promptly diagnosed and receive Read more about COVID-19 Public Health Emergency of International Concern (PHEIC)[…]

Commission launches “COVID-19 Clinical Management Support System”

The European Commission launched the “COVID-19 Clinical Management Support System” with the aim to support clinicians in hospitals that are currently facing the coronavirus emergency all over Europe. Based on the experience with the European Reference Networks, the initiative will help to create rapid connections across Europe among the hospitals indicated by the Member States as Read more about Commission launches “COVID-19 Clinical Management Support System”[…]

Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials

EMA has developed this guidance covering actions that sponsors of ongoing clinical trials affected by the coronavirus disease (COVID-19) pandemic should take to help ensure the integrity of their studies and interpretation of study results while safeguarding the safety of trial participants as a first priority. This complements the good clinical practice guidance on how sponsors should adjust the management of clinical Read more about Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials[…]